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Abstract
Although anxiety and depression often co-occur and share some clinical features, it is still unclear if 
they are neurobiologically distinct or similar processes. In this study, we explored common and 
specific cortical morphology alterations in depression and anxiety disorders. Magnetic Resonance 
Imaging data were acquired from 13 Major Depressive Disorder (MDD), 11 Generalized Anxiety 
Disorder (GAD), 11 Panic Disorder (PD) patients and 21 healthy controls (HC). Regional cortical 
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thickness, surface area (SA), volume and gyrification were measured and compared among groups. 
We found left orbitofrontal thinning in all patient groups, as well as disease-specific alterations. 
MDD showed volume deficits in left precentral gyrus compared to all groups, volume and area 
deficits in right fusiform gyrus compared to GAD and HC. GAD showed lower SA than MDD and PD 
in right superior parietal cortex, higher gyrification than HC in right frontal gyrus. PD showed higher 
gyrification in left superior parietal cortex when compared to MDD and higher SA in left postcentral 
gyrus compared to all groups. Our results suggest that clinical phenotypic similarities between major 
depression and anxiety disorders might rely on common prefrontal alterations. Frontotemporal and 
parietal abnormalities may represent unique biological signatures of depression and anxiety. 
Keywords
Generalized anxiety disorder; major depressive disorder; panic disorder; brain morphometry; MRI. 
1. Introduction
Ranked among the top ten diseases responsible for disability and mortality, anxiety and depressive 
disorders are highly prevalent among the general population and frequently comorbid across the 
entire lifespan (Hranov, 2007; Moffitt et al., 2007; King-Kallimanis et al., 2009). In particular, among 
anxiety diseases, generalized anxiety disorder (GAD) and panic disorder (PD) have among the 
highest rates of comorbidity with major depressive disorder (MDD) (Johnson and Lydiard, 1998; 
Oathes et al., 2015), ultimately leading to greater illness severity and functional impairment, 
reduced quality of life and poorer clinical outcome (Roy-Byrne et al., 2000). From a clinical point of 
view, anxiety and mood disorders share some symptoms and symptom-oriented constructs, such as 
emotion dysregulation (Campbell-Sills et al., 2006; Hofmann et al., 2012), irritability (Vidal-Ribas et 
al., 2016), attention bias (Abend and Bar-Haim, 2013; Sylvester et al., 2016), impaired social 
functioning (Saris et al., 2017) and sleep alterations (Mason and Harvey, 2014). 
In this line, it is plausible that similar etiology and pathophysiology in anxiety and depression rely 
on common genetic polymorphisms (Mackinnon et al., 1990) and neurobiological vulnerability 
(Gulley and Nemeroff, 1993). Indeed, neuroimaging evidence suggested that these disorders share 
structural, metabolic and functional brain abnormalities in regions within the prefrontal-limbic 
network, which may moderate both anhedonia and anxiogenesis. Specifically, a key role in their 
pathogenesis seems to be played by amygdala (Bellani et al., 2011; Etkin et al., 2009; Kim et al., 
2012; Massana et al., 2003; Whittle et al., 2014), which is known to be involved in glucocorticoid 
secretion (Pego et al. 2010; Schuhmacher et al., 2012), emotional processing and fear response  
(Ressler, 2010; Comte et al., 2016), as well astogether with anterior cingulate (van Tol et al., 2010) 
and prefrontal cortices (Canu et al., 2015; Shang et al., 2014), which are thought exert executive 
control on emotional behaviors (Delgado et al., 2008; Etkin et al., 2011). Alterations in amygdala-
prefrontal connectivity, both structural and functional, have emerged from studies on both anxiety 
(Kim et al., 2011; Makovac et al., 2016) and depression (Dannlowski et al., 2009; Drevets, 2000). 
Specifically, these studies suggested the presence of common connectivity deficits in these 
4
disorders by reporting a similar reduced functional coupling of a system implicated in emotion 
regulation and processing, the corticolimbic circuitry. 
Nevertheless, neuroimaging findings also suggest unique neuroanatomical profiles for these 
disorders. While structural Magnetic Resonance Imaging (MRI) studies consistently reported 
hippocampal volume reduction (Bellani et al., 2010; Caetano et al., 2004; Sheline et al., 2003; Zhao 
et al., 2017; Arnone et al., 2012) as well as thickness and volume deficits in the orbitofrontal cortex 
(Schmaal et al., 2017; Zhao et al., 2017; Arnone et al., 2012) in MDD patients, the findings on anxiety 
disorders are less consistent. Superior temporal, hypothalamic and basal ganglia volume changes 
(Hilbert et al., 2015; Terlevic et al., 2013) and temporo-parietal hyper-gyrification (Molent et al., 
2017) have been reported in GAD, while increased brainstem (Protopopescu et al., 2006) and 
reduced volume in the temporal lobe, as a whole, (Brambilla et al., 2002) have been described in 
PD. Interestingly, one of the few studies that separately compared patients with MDD and anxiety 
disorders to healthy subjects reported specific gray matter volume deficits in right inferior frontal 
gyrus in MDD, in left middle and superior temporal cortex in anxiety disorders (van Tol et al., 2010). 
Of note, a recent research on MDD and social anxiety disorder (SAD) reported common structural 
alterations in the orbitofrontal-striatal-thalamic circuit along with disorder-specific alterations, in 
visual processing areas in MDD and in precentral gyrus in SAD (Zhao et al., 2017). A recent study 
aimed at differentiating MDD from GAD found that frontal and prefrontal volume provided relevant 
differential information on the two disorders (Hilbert et al., 2017). 
Overall, despite evidence suggests both specific and common cerebral bases, a neurobiological 
model that clearly disentangles anxiety from depression has not been validated so far, and MRI 
studies that compare these disorders in terms of gray matter morphology are still lacking. 
For the first timeIn this context, the present study aims to investigate cortical morphology in MDD, 
GAD and PD to help clarify their shared and distinct neural substrates. To provide information with 
improved morphological specificity compared to the existing literature, we evaluated cortical 
thickness, surface area, volume and gyrification. These parameters reflect partially different 
properties of the cortex, which in turn are influenced by specific developmental/lifetime processes. 
Their joint investigation can advance our knowledge of the neuroanatomical underpinnings of 
anxiety and major depression.
Based on the above-mentioned evidence, we hypothesize shared alterations in regions implicated 
in emotion regulation, as well as disease-specific abnormalities in portions of frontal, temporal and 
parietal lobes. Specifically, we expect that, compared to healthy controls, a) major depression and 
anxiety disorders will show significant deficits in regions within the prefrontal cortex, which may 
underlie the shared dimension of emotional dysregulation, b) GAD and PD will show similar 
reduction in regions within the temporo-parietal network, mainly because it might be associated 
with the core clinical symptoms of anxiety disorders.  
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2. Materials and methods
2.1 Subjects
Fifty-six participants (20 males, 38.86 ± 12.96 years) took part in the study. Among them, 35 patients 
were recruited from the Outpatient Psychiatric Clinic of the University Hospital of Udine, Italy: 13 
were diagnosed with MDD (4 males, 46.68 ± 12.49 years), 11 with GAD (4 males, 42.43 ± 11.53 
years), 11 with PD (5 males, 33.55 ± 9.53 years). Exclusion criteria included the presence of other 
comorbid axis I disorders, neurological or medical disorders with possible effect on brain 
development, history of traumatic head injury with loss of consciousness and alcohol or substance 
abuse. Among patients, 2 with MMD, 3 with PD and 2 with GAD had comorbid personality disorders. 
The remaining 21 participants were healthy controls (HC) from the local community (7 males, 36.03 
± 13.46 years, 18-66 years), with no significant differences compared to patients in terms of age, 
gender and handedness (p<0.05). HC had no psychiatric axis I disorders and no history of alcohol or 
substance abuse, head trauma or neurological or major medical illnesses as well as no history of 
psychiatric disorders among first-degree relatives. Among patients, 8 with GAD (63.6%), 8 with PD 
(72.7%) and 12 with MDD (92.3%) were receiving antidepressants (8 paroxetine, 8 sertraline, 4 
escitalopram, 3 venlafaxine, 2 amitriptyline, 1 citalopram, 1 duloxetine and 1 fluoxetine). A minority 
of participants (1 HC, 2 GAD patients, 1 PD patient and 2 MDD patients) was taking part to individual 
psychotherapy sessions on a weekly or fortnightly basis. 
A written informed consent to the study protocol, approved by the competent ethical committee, 
was obtained from all participants, in accordance with the Declaration of Helsinki and local Ethical 
Committee guidelines.
2.2 Psychopathological assessment
The clinical diagnoses were based on the Italian version of the Structured Clinical Interview for Axis 
I DSM-IV disorders (SCID-I) (Spitzer et al., 1992) and confirmed by the clinical consensus of two 
expert psychiatrists. The absence of psychiatric axis I disorders in HC was determined using a brief 
non-patient version of the SCID-I. Psychopathological assessment also included the administration 
of 24-item Brief Psychiatric Rating Scale (BPRS) (Ventura et al., 2000) and Hamilton Anxiety and 
Depression Rating Scales (HARS and HDRS, respectively) (Hamilton, 1959, 1960). The Global 
Assessment of Functioning scale (GAF) (Endicott et al., 1976) was used to rate the overall social, 
occupational and psychopathological functioning. Handedness was determined using the Edinburgh 
Handedness Inventory (Oldfield, 1971).
2.3 MRI data acquisition
MRI data were acquired using a 1.5T Avanto magnetic resonance (MR) scanner (Siemens, Germany). 
A standard head coil equipped with 8 channels was used for radiofrequency transmission and 
reception. The participants’ head motion was limited by restraining foam pads. Structural brain 
images were obtained using a MPRAGE T1-weighted sequence (echo time 3.93 ms, repetition time 
2300 ms, voxel size 0.5×0.5×1 mm3, 160 transversal slices with no gap, matrix size 512×448×160).
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2.4 MRI data processing
Images were processed using FreeSurfer 5.3.0 (FS, http://surfer.nmr.mgh.harvard.edu) (Fischl, 
2012). For each subject, from the original T1-weighted image, FS performed a brain tissue 
segmentation and an accurate 3D reconstruction of cortical surfaces. The segmentation output and 
reconstructed surfaces were visually inspected and manually corrected when necessary. Each 
subject’s cortical model was then parceled into regions of interest (ROIs) based on the Desikan-
Killiany atlas (Desikan et al., 2006). Surface-based morphological measures, specifically cortical 
thickness (CT), surface area (SA), gray matter volume (GMV) and mean curvature (MC), were 
estimated at the ROI level.  To better localize any early defects of cortical development, we 
additionally computed the local gyrification index (LGI) at each vertex of the reconstructed surface. 
In the ROI study, based on clinical knowledge of the disorders and in line with our recent study on 
anxiety (Molent et al., 2017), we performed the morphological comparison on a subset of Desikan-
Killiany ROIs (isthmus, rostral-anterior, caudal-anterior and posterior cingulate cortex; lateral 
orbitofrontal, medial orbitofrontal, superior frontal, rostral middle frontal, caudal middle frontal 
and precentral gyri; postcentral, superior parietal, supramarginal and inferior parietal gyri; 
entorhinal, superior temporal, middle temporal, inferior temporal and fusiform gyri; lateral occipital 
gyrus; insula). Conversely, the vertex-based LGI comparison was performed on the entire cortical 
surface.    
2.5 Statistical analyses
The demographic, clinical and neuroimaging data (except LGI measures) were compared among 
groups on Matlab R2015a (The Mathworks, Inc) using in-house scripts based on functions from 
Statistics and Machine Learning toolbox. 
The dependency of clinical parameters on diagnosis was assessed using one-way Analyses of 
Variance (ANOVAs) followed by post-hoc pairwise comparisons across all diagnostic groups (i.e. 
patient groups versus HC and between each other). In the ANOVAs, a statistical significance 
threshold of 0.05 was adopted. In the pairwise comparisons, three levels of significance were 
considered (p<0.05, p<0.01, p<0.001). 
In the neuroimaging regional analyses, in line with our recent study on GAD (Molent et al., 2017), 
group comparisons were performed using univariate General Linear Model (GLM) designs, where 
each neuroanatomical measure was modelled considering diagnosis, sex and age. We evaluated one 
parameter (CT, SA, GMV and MC) and one ROI at a time. In the ROI GLM designs, to exclude 
confounding effects due to different head dimensions, total intracranial volume (ICV) and 
hemispheric cortical area were included as covariates in the GMV and SA analyses respectively. 
Significant effects of diagnosis on global morphology (ICV and hemispheric SA) and ROI parameters 
were assessed using ANOVAs (p<0.05), followed by post-hoc pairwise comparisons across all 
couples of groups. In the ROI comparisons, to reduce the false positive rates, a multiple comparison 
correction was performed, dividing the uncorrected p-value for the number of ROIs in each 
hemisphere (n=21). Both uncorrected (p<0.05, p<0.01) and Bonferroni’s corrected (p<0.05*) p-
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values are reported. The vertex-based LGI analyses were performed using the FS QDEC tool. Using 
the group statistics made available by QDEC, we compared two diagnostic groups at a time through 
two-tailed t-tests. As in the ROI analyses, age and sex were included as covariates, to discard their 
contribution to LGI. Both uncorrected (p<0.01) and False Discovery Rate corrected (p<0.05, FDR 
corrected) results are shown.
Secondary correlation analyses were performed to investigate the possible relation between clinical 
parameters (GAF, BPRS, HARS and HDRS scores) and regional brain morphology (CT, SA, GMV and 
MC), including case by case the subjects having the parameter of interest. More details on clinical 
scale scores and information availability can be found in Table 1. We conducted Pearson linear 
partial correlation analyses between the selected ROI parameter and clinical scale score, while 
accounting for the contribution of age, gender and, when appropriate, diagnosis. In the volume and 
area analyses, global measures were included as covariates to remove any confounding effects of 




The demographic and clinical characteristics of the population are reported in Table 1, together with 
ANOVA and post-hoc pairwise comparison results. Sex, handedness and language did not differ 
among groups, whereas differences in age and GAF, BPRS, HDRS and HARS scores emerged (p 
<0.05). While no post-hoc pairwise differences emerged in terms of age, as expected the GAF scores 
were much lower in all patient groups compared to controls (p<0.001). The opposite tendency 
emerged for the BPRS score (GAD vs. HC: p<0.001, MDD and PD vs. HC: p<0.05). Compared to HC, 
GAD and PD showed higher HARS scores (p<0.001), whereas MDD showed higher scores at the HDRS 
scale (p<0.001).
3.2 Morphological comparison among diagnostic groups
The statistics, both uncorrected and multiple comparison corrected, concerning the region-based 
GMV, SA, CT and MC comparisons are reported in Table 2. The significant differences surviving the 
Bonferroni’s correction (p<0.05*) are illustrated in Figure 1. The vertex-based LGI comparison 
results are reported in Table 3. 
3.2.1 Gray matter volume
The GMV comparison results are reported in Table 2, upper section. Although the four groups did 
not differ in terms of ICV, regional differences emerged: specifically, the ANOVAs showed a 
significant diagnosis contribution to GMV in left precentral gyrus (p<0.01) and right fusiform gyrus 
(p<0.01).
The post-hoc comparisons showed that MDD was characterized by lower GMV than the other 
groups in left precentral gyrus. Such a difference was moderately significant in MDD vs. PD (p<0.05) 
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and MDD vs. GAD (p<0.01) comparisons. When MDD patients were compared to HC, the significance 
survived the Bonferroni correction (p<0.05*) (Figure 1, a). MDD also showed GMV deficits compared 
to GAD and HC in right fusiform gyrus (p<0.01).
3.2.2 Surface area
The SA comparison results are summarized in Table 2, second section. While left and right 
hemispheric SA did not differ among groups, in line with GMV results we found a significant 
contribution of diagnosis to SA of right fusiform gyrus (p<0.01). In this region, MDD showed lower 
SA compared to both HC and GAD (p<0.05*) (Figure 1, b). On the contrary, GAD showed lower SA 
than MDD in right superior parietal cortex (p<0.01). The same tendency emerged when GAD was 
compared to PD (p<0.05). A further difference emerged in left postcentral gyrus, showing higher SA 
in PD compared to HC (p<0.01) and the other patient groups (p<0.05).
3.2.3 Cortical thickness
The significant differences emerged from Tthe CT  comparison results are listed in Table 2, third 
section. The ANOVA showed significant effects of diagnosis on CT in left orbitofrontal cortex (lateral 
portion) (p<0.01). In this region, the three patient groups showed CT deficits when compared to HC. 
Such a difference was highly significant in the GAD vs. HC comparison (p<0.05*) (Figure 1, c), less 
significant in MDD vs. HC and PD vs. HC ones (p<0.05). 
3.2.4. Mean Curvature
The results of the MC group statistics are listed in Table 2, bottom section. We found significant 
differences among diagnostic groups in right orbitofrontal cortex (medial portion) (p<0.05). In this 
region, the post-hoc pairwise comparisons revealed higher MC in GAD compared to HC (p<0.01) and 
MDD (p<0.01). 
3.2.5 Gyrification
The location and statistics of the clusters with significant LGI differences among groups are reported 
in Table 3 (p<0.01). Compared to HC, only GAD patients revealed increased gyrification in a cluster 
of right superior frontal gyrus (p<0.001). Significant LGI differences were also observed emerged 
also among the patient groups. Specifically, PD patients showed higher LGI in a portion of left 
superior parietal cortex when compared to MDD ones (p<0.01). Although no clusters survived to 
the FDR correction (p<0.05), the T statistics of the GAD vs. HC difference in right superior frontal 
gyrus was close to the FDR threshold.
3.3 Clinical-neuroanatomical analysis
The correlation analyses showed selective associations between clinical scales and cortical 
morphological parameters, after exclusion of diagnostic contribution. In our sample, we found no 
associations between (i) regional CT/SA and all clinical scale scores, (ii) HDRS scores and all ROI 
parameters. Conversely, our results suggest a link between cortical folding and clinical scores. 
Indeed, MC in right precentral gyrus was positively associated with GAF scores (rho=0.453, p= 0.001, 
surviving to Bonferroni’s correction) and negatively associated with BPRS scores (rho=-0.386, p= 
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0.008), whereas MC in left entorhinal cortex was negatively associated with BPRS scores (rho=-
0.4113, p=0.005). We also detected a negative correlation between HARS scores and GMV in left 
fusiform gyrus (rho= -0.4361, p= 0.0099).
4. Discussion
In the present study, for the first time to our knowledge, patients with GAD, PD and MDD were 
compared with HC and among themselves in terms of cortical morphology. The investigation of 
cortical thickness, volume, surface area and gyrification, which represents a main asset of the work, 
has provided specific insights in the structural abnormalities of anxiety and major depression. The 
integration of the diagnostic comparison with clinical-morphological correlation analyses has 
allowed to disentangle the contribution of common and distinct symptom dimensions.  
Although the limited sample size makes this study a pilot investigation, our results suggest the 
presence of both common and selective gray matter alterations in the three diagnostic groups, 
which will be discussed in view of shared and distinct characteristics of anxiety and major 
depression.  
4.1 Orbitofrontal abnormalities in the patient groups
We found orbitofrontal cortex (OFC) thinning in all diagnostic groups compared to HC. Since cortical 
thickness is thought to be sensitive to maturational changes, this neuroanatomical abnormality may 
result from developmental processes and underlie functional deficits shared by these disorders. 
Indeed, the OFC is a key region involved in decision making (Stalnaker et al., 2015) and in the 
processing of reward and punishment stimuli (Volz and von Cramon, 2009), abilities often found to 
be impaired in patients with MDD (Leykin et al., 2011; Martin-Soelch, 2009), GAD (Beesdo et al., 
2010; Teng et al., 2016) and PD (Held-Poschardt et al., 2018; Ludewig et al., 2003). This evidence is 
also supported by previous neuroimaging findings on both anxiety and depression. Structural 
abnormalities in this region emerged from several neuroimaging studies on MDD. A meta-analysis 
of brain volume abnormalities in MDD reported reduced volume in OFC - especially in the left 
hemisphere - in patients compared to HC (Arnone et al., 2012). A more recent publication carried 
out by the ENIGMA-MDD working group showed that adult MDD patients (n=1902) showed reduced 
cortical thickness in medial OFC, and in other portions of frontal/temporal lobes compared to HC 
(Schmaal et al., 2017). 
Notably, The findings on anxiety disorders are fewer but in the same line of ours. tThe role of OFC 
in anxiety neurocircuitry has been largely investigated and acknowledged, suggesting a key 
involvement of this region in the altered fear extinction and top-down inhibition of emotion 
processing characterizing anxiety (Milad and Rauch, 2007). Cortical thinning in medial OFC, but in 
the right hemisphere, was suggested as a neuroanatomical precondition for anxiety, being 
associated with trait anxiety score in healthy volunteers (Kuhn et al., 2011). In this exact region, our 
GAD sample showed higher curvature compared to HC and MDD. These findings are not in conflict, 
since curvature is usually negatively correlated with thickness. Of note, our recent study on an 
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independent sample of GAD patients and HC already highlighted CT deficits in left lateral OFC in 
GAD (Molent et al., 2017). Conversely, studies on PD described CT deficits in the pars triangularis of 
the inferior frontal gyrus, enhanced in the left hemisphere (Kang et al., 2017). Structural deficits in 
left medial OFC recently emerged as a specific trait of PD with agoraphobia (Na et al., 2013), clearing 
the way for further investigations.
4.2 Unique brain alterations in MDD
Our results showed a significant reduction of GMV within left precentral gyrus in MDD compared to 
both HC and the other two patient groups. These findings are supported by recent studies that 
investigated cerebral vulnerability for MDD and mood disorders, highlighting a possible role of 
precentral region in MDD pathogenesis. In a work focusing on thickness, which is known to 
contribute to volumetric estimates, decreased CT in left precentral region emerged from first 
episode drug naïve MDD patients, and progressive cortical thinning in the precentral gyri was 
suggested as an increased risk factor for mood disorders (Papmeyer et al., 2015). A recent study 
also hypothesized a role for this region in suicidality, showing that MDD patients with a story of 
suicidal acts had lower activation in left precentral gyrus compared to non-suicide attempters (Tsujii 
et al., 2017). Of note, our correlation analyses showed that precentral gyrification (but in the right 
hemisphere) is proportional to global functioning, which further supports its key role in 
psychopathology.
We also found that MDD patients had GMV and SA deficits compared to GAD patients and HC in 
right fusiform gyrus, a region engaged in recognition of facial expressions (Brunye et al., 2017; Grill-
Spector and Weiner, 2014). This finding is supported by a recent meta-analysis of voxel-based 
morphometry studies, which showed that MDD is associated with GMV deficits in right fusiform 
gyrus (Arnone et al., 2016). 
Therefore, overall this evidence suggests that fusiform gyrus deficits might play a key role in the 
pathophysiology of MDD and of affective disorders in general (Marotta et al., 2018; Hibar et al., 
2017) and could explain the specific clinical manifestations of this disabling illness. Indeed, since the 
fusiform gyrus has been found to be involved in the early visual processing of affective stimuli, it 
might be plausible that deficits in this structure are linked to one of the most common cognitive 
features of MDD, the bias toward negatively affective stimuli (Surgulaze et al., 2005). While the right 
side of fusiform gyrus seems to be involved in MDD, the contralateral region might contribute to 
anxiety. Indeed, we found an inverse relationship between left fusiform gyrus volume and anxiety 
symptom severity, which supports the functional involvement of this region in the processing of 
social anxiety signals (Prehn-Kristensen, 2009).
4.3 Unique brain alterations in GAD
Our results suggest that hyper-gyrification in right frontal cortex represents a specific abnormality 
of GAD patients compared to HC. Frontal cortical folding abnormalities in GAD emerged from both 
vertex-based analyses, although as a tendency, and region-based analyses. Local gyrification and 
regional curvature are different measures of cortical folding computed at different spatial scales. 
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Their combination allowed to provide deeper insight in the cortical developmental defects 
associated with GAD. Our findings corroborate evidence from our previous MRI study on GAD and 
HC, showing superior frontal hyper-gyrification in GAD patients (Molent et al., 2017), and may be 
linked to prefrontal metabolic and functional alterations already described in GAD (Delvecchio et 
al., 2017; Diwadkar et al., 2017). Since cortical gyrification results from dynamic processes during 
brain development (Kim et al., 2016) and is related to the underlying cortical connectivity (Van 
Essen, 1997), our finding may reflect abnormal connections between right frontal region and the 
rest of the brain, providing possible insights into GAD pathogenesis. 
Moreover, GAD was associated with SA deficits in right superior parietal cortex compared to MDD 
and PD. Since the only MRI study that compared MDD and GAD did not inspect the parietal lobe 
(Hilbert et al., 2017), our results cannot be discussed in the light of previous ones. Nonetheless, the 
involvement of the parietal cortex in GAD is in line with previous evidence from an fMRI study, which 
reported that during both neutral and anxiety distractors GAD patients showed significantly lower 
activation than HC in superior parietal gyrus (Moon and Jeong, 2015) as well as from a diffusion 
study, which reported a disruption of white matter microstructure organization in right parietal 
cortex in GAD patients compared to HC (Brambilla et al., 2012). The parietal cortex represents an 
important area involved in spatial orientation, sensory motor integration processes, movement 
control, movement observation, action prediction, planning and execution (Teixeira et al., 2014). 
This structure is also involved in the frontoparietal network, whose activity has been demonstrated 
to be less recruited in GAD patients (Pico-Perez et al., 2017), especially during processing of neutral 
stimuli (Holzel et al., 2013). Notably, this result further supports the hypothesis that deficits within 
the parietal cortex might be considered a putative biomarker of GAD, which may underpin its 
pathophysiology. Indeed, the superior parietal abnormalities in GAD patients compared to the other 
patient groups might sustain the key deficits often observed in this disorder in respect to other 
anxiety and mood illnesses, especially the difficulty in concentrating and sleep disturbances. 
4.4 Unique brain alterations in PD
In our study, PD patients showed a trend towards hyper-gyrification in a cluster in left superior 
parietal cortex compared to MDD ones. Although gyrification had never been compared between 
the two patient groups, an involvement of this region in PD pathophysiology is plausible. Indeed, 
cerebral blood flow abnormalities in left parieto-temporal cortex were already described in PD 
(Meyer et al., 2000), moreover the electrical stimulation of this region was found to induce panic 
attacks (Penfield and Jasper, 1954). Panic symptoms may therefore arise from abnormal perception 
and sensation processing due to potential parietal alterations, possibly being related to inadequate 
multisensory integration, and transmission of false input to frontal areas and limbic circuits (LeDoux 
and Brown, 2017).
Our group of PD patients also revealed larger SA in left postcentral gyrus compared to the other 
groups. The postcentral gyrus encompasses the primary somatosensory cortex and represents the 
primary receptor of general bodily sensation (Borich et al., 2015). Interestingly, a previous fMRI 
study showed that PD patients had greater functional connectivity between somatosensory cortex 
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and thalamus that was interpreted as linked to greater interoceptive processing (Cui et al., 2016), 
which plays a key role in symptom generation in PD (Ehlers and Breuer, 1996). Consistently, PD 
exhibits exaggerated functional connectivity between postcentral gyrus and thalamus (Marchand et 
al., 2009), which may determine the inadequate integration of stimuli and elaboration of specific 
somatic feelings, ultimately providing a disturbed awareness of somatosensory information 
(Domschke and Dannlowski, 2010). It is worth to highlight that the postcentral abnormalities 
emerged also when PD was compared with MDD and GAD, therefore suggesting that areas involved 
in somatosensory processing are more likely to specifically characterize patients with somatic 
symptoms, mainly in interceptive processing, rather than a general chronic and excessive sense of 
anxiety and worrying, which is a central feature of GAD. Indeed, the structural alteration of the 
postcentral gyrus might explain the peculiar symptoms of PD, which include the abnormal 
perception of bodily signals, including the extreme feeling of heartbeat. 
4.5 Limitations
Our findings should be considered in light of some limitations. First, the small sample size did not 
allow to fully balance our sample in terms of age, which however was taken into account in the 
analysis design. The modest sample size also limited also the statistical power of the study, 
preventing from extracting subtle structural changes among the groups and from stratifying each 
patient group based on clinical characteristics that may affect the results. To partially face this issue, 
we stratified the statistical threshold and discussed the results in view of their significance level. 
Although all findings need to be confirmed by replications on larger samples, the emergence of 
significant results from our small sample supports their reliability. 
Another issue concerned the substantial comorbidity between mood and anxiety disorders. 
Although patients with comorbid Axis I disorders were excluded from the comparison, we cannot 
completely rule out related confounders, including past Axis I and current Axis II comorbidities, from 
our results. In the clinical-neuroanatomical correlation analyses, the partial availability of clinical 
scale scores has limited the possibility to explore the structural bases of common symptom 
dimensions. Finally, it should be remarked that most patients were on antidepressant treatment at 
the time of the study, which might have had an impact on our morphological parameters, as 
suggested by previous investigations (Arnone et al., 2013) and therefore limited the generalizability 
of our findings. Therefore, future larger studies on homogenous drug-naïve samples are needed for 
better identifying the structural correlates associated with anxiety and depressive illnesses.
4.6 Future directions
In the near future, our surface-based results should be integrated with voxel-based statistics to 
provide a more complete understanding of the structural correlates of anxiety and major 
depression. 
Since our study remarks the importance of understanding the biological underpinnings of mood and 
anxiety disorders, future larger neuroimaging studies further investigating the etiology and 
pathophysiology of these disabling and highly prevalent disorders are warranted. Indeed, the use of 
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more homogeneous samples, especially in terms of pharmacological treatment and socio-
demographic variables, might allow to identify the neurobiological models of these disorders, which 
may ultimately facilitate the early identification of these diseases and new targeted treatments.   
4.7 Conclusive remarks
This study,  for the first time to our best knowledge, highlighted the importance of investigating 
common and specific cortical morphology alterations in PD, GAD and MDD for delineating their 
neurobiological underpinnings. 
In all diagnostic groups, we found orbitofrontal alterations that possibly reflect a similar abnormal 
top-down cognitive control, which in turn might explain the emotion dysregulation often observed 
in anxiety and major depression. We also detected unique brain alterations, with MDD showing 
deficits in frontotemporal structures, and GAD and PD characterized by selective alterations in 
parietal regions.
Overall, these results suggest that clinical phenotypic similarities between major depression and 
anxiety may be associated with common neurobiological alterations in the prefrontal cortex. 
Moreover, they support the hypothesis that GAD and PD share some neural substrates, as expected 
since they belong to the same nosological class, while being characterized by specific signatures that 
might explain their key clinical symptoms. Finally, future larger MRI investigations are needed to 
unveil the role of the frontotemporal and parietal cortices, which may help in refining the 
differential diagnosis of these illnesses.
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Tables
Table 1. Characteristics of the sample.
Characteristica GAD (n = 11) PD (n =11) MDD (n=13) HC (n = 21) ANOVA Pairwise comparison
Gender (M/F) 4/7 5/6 4/9 7/14 n.s. n.s.







(Italian/other) 10/1 11/0 12/0 20/1 n.s. n.s
Handedness 
(EHI) 15.64 ± 11.40 18.44 ± 3.75 19.64 ± 0.81 17.68 ± 8.67 n.s. n.s.

































a For continuous variables, mean ± standard deviation is given. M=maleMale; F=femaleFemale; GAD= General 
Anxiety Disorder; PD=: Ppanic Ddisorder; MDD=: major Major depressive Depressive Ddisorder; HC= Healthy 
Controls; ANOVA=: analysis Analysis of Of varianceVariance; EHI= Edinburgh handedness Handedness 
inventoryInventory; BPRS=Brief Psychiatric Rating Scale; GAF= Global assessment Assessment of 
functioningFunctioning; HDRS= Hamilton Depression Rating Scale; HARS= Hamilton Anxiety Rating Scale; n.s.= not 
significant; n.a.= not available. d1= F-test numerator degree of freedom. d2= F-test denominator degree of freedom.
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Table 2. Regional morphological comparison results.
Brain region Hemisphere Measure ANOVA Pairwise comparisons




Fusiform gyrus Right Volume F=4.37, p=0.009 (d1=6, d2=49)
MDD<HC: T=2.96, p<0.01
MDD<GAD: T=3.16, p<0.01




Fusiform gyrus Right Area F=5.18, p=0.004 (d1=6, d2=49)
MDD<HC: T=3.29, p<0.05*
MDD<GAD: T=3.27, p<0.05*
















GAD= General Anxiety Disorder; HC= Healthy Controls; PD= Ppanic disorderDisorder; MDD=major Major depressive 
Depressive disorderDisorder; ANOVA= analysis Analysis of Of varianceVariance. T= T statistics; F= F statistics. d1=F-
test numerator degrees of freedom. d2=F-test denominator degrees of freedom. ICV= total Total intracranial 
Intracranial volumeVolume.
* Significant after Bonferroni correction (n=21).
General Linear Model designs:
ROI volume ~ 1 + Diagnosis + Gender + Age + ICV
ROI thickness ~ 1 + Diagnosis + Gender + Age
ROI area ~ 1 + Diagnosis + Gender + Age + hemispheric area
ROI mean curvature ~ 1 + Diagnosis + Gender + Age.
Table 3. Local gyrification index comparison results.
Result Brain region Hemisphere Cluster size (mm2) T-statistics, p-value
GAD > HC Superior frontal Right 452.48 T=3.60, p=0.07×*10
-2 
(df=24)   
PD > MDD Superior parietal Left 311.48 T=3.17, p=0.002 (df=16)
GAD= General Anxiety Disorder; HC= Healthy Controls; PD= Ppanic disorderDisorder; MDD=major Major depressive 
Depressive disorderDisorder.
General Linear Model designs:
LGI ~ 1 + Diagnosis + Gender + Age 
Figure legends
Figure 1. Results of regional morphology comparison. Regions with significant 
differences in regional morphological parameters (cortical volume, surface area and thickness) among the 
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four groups of subjects (major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder 
(PD) and healthy controls (HC)) (ANOVAs: p<0.05, post-hoc pairwise comparisons: p<0.05*, Bonferroni 
corrected (n=21)). The diagrams show the minimum, maximum, median, and 25th and 75th percentiles of 
the considered morphological parameter in the four groups. The asterisks mark pairwise significant 
differences surviving Bonferroni correction. 

